|
|
Volumn 2, Issue 3, 2004, Pages 101-106
|
|
Postmenopausal osteoporosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
AGED;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
FEMALE;
FOLLOW UP;
HORMONE SUBSTITUTION;
HOSPITALIZATION;
HUMAN;
INCIDENCE;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGIC FRACTURE;
POSTMENOPAUSE OSTEOPOROSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
TREATMENT OUTCOME;
AGED;
DIPHOSPHONATES;
ESTROGEN RECEPTOR MODULATORS;
FEMALE;
FOLLOW-UP STUDIES;
FRACTURES, SPONTANEOUS;
HORMONE REPLACEMENT THERAPY;
HUMANS;
INCIDENCE;
MIDDLE AGED;
OSTEOPOROSIS, POSTMENOPAUSAL;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 23944469425
PISSN: 15441873
EISSN: None
Source Type: Journal
DOI: 10.1007/s11914-004-0018-y Document Type: Review |
|
Times cited : (14)
|
|
References (32)
|
